Efficacy of orchiectomy versus high dose polyoestradiol phosphate (160 mg) in relieving infravesical obstruction in patients with prostatic cancer

Marshall, V. F.: Editorial: The choice of therapy for prostatic carcinoma.J. Urol., 113, 285 (1975).

Carpentier, P. J., Schroeder, F. H., Blom, J. H. M.: Transrectal ultrasonography in the followup of prostatic carcinoma patients.J. Urol., 128, 742 (1982).

Ohe, H.: Kinetics of prostatic size reduction in treating prostatic cancer. In: The World Congress for Ultrasound in Medicine and Biology (1979). Abstract No. 4, p. 63.

Varenhorst, E., Ålund, G.: Urethral obstruction secondary to carcinoma of prostate: response to endocrine treatment.Urology, 25 (4), 354 (1985).

Aro, J. L. V., Haapiainen, R. K., Rannikko, S. A. S., Alfthan, O. S. and The Finnprostate Group: High dose polyoestradiol phosphate with and without acetosalicylic acid versus orchiectomy in the treatment of prostatic cancer.Br. J. Urol. (in press).

Alfthan, O., Mattson, Z.: Ultrasonic method of measuring residual urine.Ann. Chir. Gynaecol. Fenn., 58, 300 (1969).

UICC TNM classification of malignant tumours. 4th fully revised edition, 1987.

Carpentier, P. J., Schroeder, F. H., Schmitz, P. I. M.: Transrectal ultrasonometry of the prostate: the prognostic relevance of volume changes under endocrine management.World J. Urol., 4, 159 (1986).

Michigan, S., Catalona, W. J.: Ureteral obstruction from prostatic carcinoma: response to endocrine and radiation therapy.J. Urol., 118, 733 (1977).